Global Information
회사소개 | 문의 | 위시리스트

PCR 시장 : qPCR, dPCR, 싱글플렉스, 멀티플렉스 시장 - 이그제큐티브 및 컨설턴트 가이드, 맞춤형 예측과 분석(2020-2024년)

PCR Markets: Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets with Executive and Consultant Guides, Including Customized Forecasting and Analysis 2020 to 2024

리서치사 Howe Sound Research
발행일 2019년 06월 상품 코드 854116
페이지 정보 영문 276 Pages
가격
US $ 5,995 ₩ 7,166,000 PDF by E-mail (Single User License) help
DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로 1대의 PC에서만 이용할 수 있는 라이선스로 인쇄가 불가능합니다.
US $ 8,995 ₩ 10,752,000 PDF by E-mail (Five User License) help
DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로 5대의 PC에서만 이용할 수 있는 라이선스로 인쇄가 불가능합니다.
US $ 11,995 ₩ 14,338,000 PDF by E-mail (Enterprise License) help
동일기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 편집 및 인쇄는 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



PCR 시장 : qPCR, dPCR, 싱글플렉스, 멀티플렉스 시장 - 이그제큐티브 및 컨설턴트 가이드, 맞춤형 예측과 분석(2020-2024년) PCR Markets: Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets with Executive and Consultant Guides, Including Customized Forecasting and Analysis 2020 to 2024
발행일 : 2019년 06월 페이지 정보 : 영문 276 Pages

싱글플렉스 검사는 이제 구식일까요? 일상적 암검사가 현실화될까요? 주치의 및 가정에서 진단이 가능해질까요? 디지털 PCR이 새로운 시험기관의 기준이 될까요?

세계의 PCR 시장에 대해 조사했으며, 시장의 현황과 향후 동향, 성장 기회, 지역별 동향, 시장 참여 기업의 개요에 대해 정리하여 전해드립니다.

시장 가이드

제1장 서론과 시장의 정의

  • PCR 기술이란?
  • PCR : 뉴 호라이즌
  • 시장의 정의
  • 조사 방법
  • 미국의 의료 시장과 시험기관 검사 : 전망

제2장 PCR 기술의 가이드

  • PCR
  • 컨셉
  • 응용
  • PCR : 장단점
  • 다양한 종류의 PCR

제3장 업계 개요

  • 시장 참여 기업

제4장 시장 동향

  • 성장 촉진요인
  • 성장 저해요인
  • 치료 기술 개발

제5장 PCR의 최근 발전

제6장 PCR 기업의 개요

제7장 PCR 시장

  • 국가별 시장 개요

제8장 세계의 PCR 시장 : 용도별

  • 개요
  • 임상 멀티플렉스
  • 임상 싱글플렉스
  • 연구
  • 법의학
  • 기타

제9장 기술별 시장

  • 개요
  • qPCR
  • dPCR
  • 기타

부록

KSA 19.06.12

Table of Tables

  • TABLE 1: List of Cancers by Mortality
  • TABLE 2: Lab Spending 2014 to 2024
  • TABLE 3: Market Players by Type
  • TABLE 4: Five Factors Driving Growth
  • TABLE 5: Three Factors Limiting Growth
  • TABLE 6: GLOBAL PCR MARKET BY REGION
  • TABLE 7: GLOBAL MARKET BY APPLICATION
  • TABLE 8: PCR CLINICAL MULTIPLEX BY COUNTRY
  • TABLE 9: PCR CLINICAL SINGLEPLEX BY COUNTRY
  • TABLE 10: PCR RESEARCH BY COUNTRY
  • TABLE 11: PCR FORENSIC BY COUNTRY
  • TABLE 12: PCR OTHER BY COUNTRY
  • TABLE 13: GLOBAL MARKET BY TECHNOLOGY
  • TABLE 14: QPCR BY COUNTRY
  • TABLE 15: DPCR BY COUNTRY
  • TABLE 16: OTHER PCR BY COUNTRY
  • TABLE 17: 2018 Clinical Lab Fee Schedule

Table of Figures

  • FIGURE 1: Cancer Death Rates - USA, CDC
  • FIGURE 2: Clinical Lab Spending 2014 to 2024
  • FIGURE 3: The PCR Process
  • FIGURE 4: Creation of Sample Droplets for Digital PCR
  • FIGURE 5: Comparing Syndromic and Targeted Testing
  • FIGURE 6: Comparing The New Diagnostics and Traditional Testing
  • FIGURE 7: Growth rates of DiagnosticTechnologies
  • FIGURE 8: 2018 Global Market Density Chart
  • FIGURE 9: PCR Market by Application - 2019 vs. 2024
  • FIGURE 10: PCR MARKET 2019
  • FIGURE 11: PCR MARKET 2024
  • FIGURE 12: APPLICATION SHARE BY YEAR
  • FIGURE 13: PCR CLINICAL MULTIPLEX TESTING GROWTH
  • FIGURE 14: PCR CLINICAL SINGLEPLEX TESTING GROWTH
  • FIGURE 15: PCR RESEARCH GROWTH
  • FIGURE 16: PCR FORENSIC GROWTH
  • FIGURE 17: PCR OTHER GROWTH
  • FIGURE 18: PCR MARKET BY TECHNOLOGY - 2019 VS. 2024
  • FIGURE 19: PCR MARKET 2019
  • FIGURE 20: PCR MARKET 2024
  • FIGURE 21: TECHNOLOGY SHARE BY YEAR
  • FIGURE 22: QPCR GROWTH
  • FIGURE 23: DPCR GROWTH
  • FIGURE 24: OTHER PCR GROWTH

“PCR Markets Enter Digital Age Poised to Dominate Diagnostic Markets...“

OVERVIEW:

Are singleplex tests going to be obsolete? Will routine cancer screening become a reality? Will diagnostics move into the Physician's Office or even the Home? Will digital PCR become the new lab standard?

Our facts and support = Your success.

The report forecasts the market size out to 2024 with the only analysis available that breaks out Singleplex and Multiplex testing markets. PCR has proved itself in the market. And the new generation of PCR, digital PCR promises to keep that success going. New levels of sensitivity have implications for Liquid Biopsy and Cancer Screening markets. Lowering costs, improving outcomes and even helping in the battle against Anti Microbial Resistance. Learn about this market including the issues and outlooks. The two key trends of Point of Care Testing and Molecular Diagnostics are merging with spectacular success.

Our research makes you the expert in your organization. Get our research team working for you by ordering this comprehensive report. Your credit card order sends the report to your inbox instantly. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to a wider license. We wrote this report and we are ready, by phone or email, to help you use it. As always, assistance, and additional specific data, is provided without additional charges.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

i. Market Guides

  • iA. Situation Analysis
  • iB. Guide for Executives and Marketing Staff
  • iC. Guide for Investment Analysts and Management Consultants

1. Introduction and Market Definition

  • 1.1. What are PCR Technologies?
  • 1.2. PCR - New Horizons
    • 1.2.1. PCR and Syndromic Testing
  • 1.3. Market Definition
    • 1.3.1. Market Size
    • 1.3.2. Currency
    • 1.3.3. Years
  • 1.4. Methodology
    • 1.4.1. Authors
    • 1.4.2. Sources
  • 1.5. U.S. Medical Market and laboratory Testing - Perspective
    • 1.4.1. U.S. Medicare Expenditures for Laboratory Testing

2. PCR - Guide to PCR Technologies

  • 2.0. PCR
  • 2.1. Concepts
    • 2.1.1. Method
  • 2.2. Applications
    • 2.2.1. Finding Specific DNA
    • 2.2.2. Measuring DNA
    • 2.2.3. Medical and diagnostic applications
      • 2.2.3.1. Carrier, prenatal and tissue typing
      • 2.2.3.2. Cancer Diagnosis and Management
      • 2.2.3.3. Infectious disease - New Levels of Accuracy and Sensitivity
      • 2.2.3.4. Forensic applications
      • 2.2.3.5. Science and Research
  • 2.3. PCR - Advantages and Disadvantages
  • 2.4. Different Types of PCR
    • 2.4.1. Simple Changes
      • 2.4.1.1. Multiplex-PCR
      • 2.4.1.2. VNTR PCR
      • 2.4.1.3. Asymmetric PCR
      • 2.4.1.4. Long PCR
      • 2.4.1.5. Nested PCR
      • 2.4.1.6. Quantitative PCR
      • 2.4.1.7. Hot-start PCR
      • 2.4.1.8. Touchdown PCR
      • 2.4.1.9. Assembly PCR
      • 2.4.1.10. Colony PCR
      • 2.4.1.11. Suicide PCR
      • 2.4.1.12. Cold PCR
    • 2.4.2. Digital PCR
      • 2.4.2.1. Droplet Digital PCR
      • 2.4.2.2. Comparison between dPCR and Real-Time PCR (qPCR)
      • 2.4.2.3. Digital PCR in Use
      • 2.4.2.4. Digital PCR Commercial History
    • 2.4.3. Isothermal PCR

3. Industry Overview

  • 3.1. Players in a Dynamic Market
    • 3.1.1. Academic Research Lab
    • 3.1.2. Diagnostic Test Developer
    • 3.1.3. Genomic Instrumentation Supplier
      • 3.1.3.1. Cell Separation and Viewing Instrumentation Supplier
    • 3.1.4. Pharmaceutical/Reagent Supplier
    • 3.1.5. Independent Testing Lab
    • 3.1.6. Public National/regional lab
    • 3.1.7. Hospital lab
    • 3.1.8. Physician Lab
    • 3.1.9. Audit Body
    • 3.1.10. Certification Body

4. Market Trends

  • 4.1. Factors Driving Growth
    • 4.1.1. A New Standard
    • 4.1.2. Down the Curve We Go
    • 4.1.3. Multiplexing
    • 4.1.4. Syndromic Diagnostics Looks Unstoppable
    • 4.1.5. The Genetic Blizzard
  • 4.2. Factors Limiting Growth
    • 4.2.1. The Cost Curve
    • 4.2.2. The Other Guys
    • 4.2.3. Systemic Roadblocks
  • 4.3. Diagnostic Technology Development
    • 4.3.1. The Instrumentation Curve
    • 4.3.2. Shifting Role of Diagnostics
    • 4.3.3. Diagnostics Moves Out of the Lab
      • 4.3.3.1. What About Imaging?
    • 4.3.4. Disruption Looms
    • 4.3.5. The Next Five Years

5. PCR Recent Developments

  • 5.1. Recent Developments - Importance and How to Use This Section
    • 5.1.1. Importance of These Developments
    • 5.1.2. How to Use This Section
      • QIAGEN Plans for Next-Generation Digital PCR Systems
      • Bioneer HIV-1 Dx Kit Gets Korea FDA Approval
      • New PCR Technology: Transfer-PCR (tPCR) Applications
      • NimaGen Licenses PCR Tech from Salisbury NHS Foundation Trust
      • Natera Applies Massively Multiplexed PCR to Kidney Transplants
      • Paragon Genomics, MGI Tech Form Distribution Alliance
      • Synlab Pharma, Biotype Collaborate on Gastrointestinal, Endometrial Cancers
      • Qiagen, NeuMoDx Ink Partnership, Merger Agreement
      • Bruker to Acquire Majority in Hain Lifescience GmbH
      • Curetis to Cut 30 Percent of Workforce as Part of Strategic Restructuring
      • Cancer Early Detection Firm Ark Launches With $40M Series A Investment
      • PredictImmune Wins £100K Grant for Study of IBD Prognostic
      • Biocartis, AstraZeneca Partner on European Lung Cancer Biomarker Study
      • llumina Ventures Leads €16M Series A Investment in Digital PCR Firm Stilla Technologies
      • Bio-Rad Wins USDA Food Safety Testing Contract
      • Luminex, XCR Diagnostics Sign Nucleic Acid Amplification Tech Licensing Deal

6. Profiles of Key PCR Companies

  • Abbott Diagnostics (Alere)
  • Accelerate Diagnostics
  • Agilent
  • Alveo Technologies
  • Applied BioCode
  • Atlas Genetics
  • Aus Diagnostics
  • BD Diagnostics
  • Biocartis
  • BioFire Diagnostics
  • bioMérieux
  • Bioneer
  • Bio-Rad Laboratories
  • Bosch Healthcare Solutions GmbH
  • Bruker
  • Cepheid
  • Curetis
  • Diagenode Diagnostics
  • Diasorin
  • Fluidigm
  • Fusion Genomics.
  • GenePOC Diagnostics
  • GenMark Dx
  • Hologic
  • Invetech
  • Janssen Diagnostics
  • Karius
  • Lexigene
  • Luminex
  • Mesa Biotech
  • Mobidiag
  • Nanomix
  • Panagene
  • Precipio
  • Primerdesign
  • Prominex
  • Qiagen (Statdx)
  • Quantumdx
  • Roche Molecular Diagnostics
  • Seegene
  • Stilla Technologies
  • Siemens Healthineers (Fast Track Diagnostics)
  • SkylineDx
  • T2 Biosystems
  • Thermo Fisher
  • Veramarx
  • XCR Diagnostics

7. The PCR Markets

  • 7.1. PCR - Global Market Overview by Country
    • 7.1.1. Table - Global Market by Country
    • 7.1.2. Chart - Global Market by Country

8. Global PCR Markets - By Application

  • 8.1. Global Market by Application - Overview
    • 8.1.1. Table - Global Market by Application
    • 8.1.2. Chart - Global Market by Application - 2019/2024 Comparison
    • 8.1.3. Chart - Global Market by Application - 2019
    • 8.1.4. Chart - Global Market by Application -2024
    • 8.1.4. Chart - Global Market by Application - Share by Year
  • 8.2. PCR Clinical Multiplex
    • 8.2.1. Table PCR Clinical Multiplex Testing - by Country
    • 8.2.2. Chart - PCR Clinical Multiplex Testing Growth
  • 8.3. PCR Clinical Singleplex
    • 8.3.1. Table PCR Clinical Singleplex Testing - by Country
    • 8.3.2. Chart - PCR Clinical Singleplex Testing Growth
  • 8.4. PCR Research
    • 8.4.1. Table PCR Research - by Country
    • 8.4.2. Chart - PCR Research Growth
  • 8.5. PCR Forensic
    • 8.5.1. Table PCR Forensic - by Country
    • 8.5.2. Chart - PCR Forensic Growth
  • 8.6. PCR Other
    • 8.6.1. Table PCR Other - by Country
    • 8.6.2. Chart - PCR Other Growth

9. Global PCR Markets - By Technology

  • 9.1. Global Market by Technology - Overview
    • 9.1.1. Table - Global Market by Technology
    • 9.1.2. Chart - Global Market by Technology - 2019/2024 Comparison
    • 9.1.3. Chart - Global Market by Technology - 2019
    • 9.1.4. Chart - Global Market by Technology -2024
    • 9.1.4. Chart - Global Market by Technology - Share by Year
  • 9.2. qPCR
    • 9.2.1. Table qPCR - by Country
    • 9.2.2. Chart - qPCR Growth
  • 9.3. dPCR
    • 9.3.1. Table dPCR - by Country
    • 9.3.2. Chart - dPCR Growth
  • 9.4. Other PCR
    • 9.4.1. Table Other PCR - by Country
    • 9.4.2. Chart - Other PCR Growth

Appendices

  • I. United States Medicare System: 2018 Clinical Laboratory Fees Schedule - National Limit and Midpoint
  • II. FDA Approved Microbial Tests
Back to Top
전화 문의
F A Q